MyImmunome

AI-powered Diagnosis & Healthcare Analytics

Get Verified & Update Profile Claimed profiles go to the top of search results. Get verified now, it takes just a couple minutes. Visit Report

A sophisticated analytical platform that transforms single-cell tumor and immune microenvironment datasets into extensive, interpretable reports without requiring coding expertise. It offers key features such as immune archetype classification, response and resistance scoring, checkpoint activity assessment, identification of immunosuppressive mechanisms, and ranking of potential targeted therapy candidates, addressing the challenge of translating complex single-cell data into actionable immunotherapy insights. Designed for researchers, clinicians, and bioinformaticians, this tool enables rapid, evidence-based evaluation of tumor immune landscapes across multiple cancer types, ultimately supporting precision immuno-oncology decision-making and personalized treatment planning.

MyImmunome can be found in AI-powered Diagnosis & Healthcare Analytics categories.

The most similar products to MyImmunome are:

stockportfolio Verified profile Promoted → Parse Biosciences → aimed analytics →

Screenshots

Details

MyImmunome Main Features

• Fast results
  Get a report in minutes about the tumor and immune system.
• High accuracy
  It has a high accuracy score (0.97) in predicting melanoma immunotherapy response.
• Simple workflow
  Use it in three easy steps without needing any coding skills, just upload your data.
• Easy to use demo
  You can launch a live demo without writing any code.
• Exportable report
  You can explore, download, and share a complete report of the analysis.
• Research use only
  The tool is for research use and uses public, de-identified data.
• No diagnostic claim
  It is only for research and not for diagnosing diseases.
• Survival validation
  It has been tested and validated with patient survival data across many cancers.
• Suppressor detection
  Identifies the main immunosuppressive factors like Tregs, MDSCs, and M2-TAMs that hold back the immune response.
• Multiple cancer types
  Works with data from 19 types of cancer and about 7,000 patients.
• Target identification
  Finds candidate targets for therapies like CAR-T, TCR, or vaccines, with information on expression and specificity.
• Identifies immune types
  Determines if the tumor is hot/inflamed, cold/excluded, or immune-desert, based on reference data.
• Checkpoints and exhaustion
  Shows levels of immune checkpoints and T-cell exhaustion, and potential for reinvigoration.
• Response and resistance scores
  Provides scores that show how the tumor might respond or resist immunotherapy.
• Single-cell tumor–immune intelligence
  It analyzes single-cell tumor data to show the immune environment in the tumor.

Verified Badge

<a href="https://saasbrowser.com/en/saas/1608215/myimmunome" target="_blank" rel="noopener"><img src="https://files.saasbrowser.com/aadvnreixpqq5wdc0n33723didrp" alt="MyImmunome - SaaS Browser Verified Badge" width="200" height="133" /></a>

Copy Badge

<a href="https://saasbrowser.com/en/saas/1608215/myimmunome" target="_blank" rel="noopener"><img src="https://files.saasbrowser.com/6cxx1ixda4ysnnan4aa9kyqwdahb" alt="MyImmunome - SaaS Browser Verified Badge" width="200" height="133" /></a>

Copy Badge

MyImmunome Alternatives

stockportfolio

Verified profile

Promoted

This platform provides a comprehensive and user-friendly dashboard designed f...

Parse Biosciences

This comprehensive single cell sequencing technology enables researchers to a...

aimed analytics

This innovative platform facilitates seamless, automated analysis of omics an...

Technologies Used

View All Technologies